GSK and Sanofi join forces to work on coronavirus vaccine
by Hannah Devlin Science correspondent from on (#524C6)
Two companies jointly have capacity to manufacture hundreds of millions of doses
Two of the world's biggest vaccine companies have joined forces in an "unprecedented" collaboration to develop a Covid-19 vaccine.
GlaxoSmithKline and Sanofi, which combined have the largest vaccine manufacturing capability in the world, are working together on a hi-tech vaccine they say could be in human trials within months.
Continue reading...